Search Results for “New LFCA Test Score Report Free PDF | Valid LFCA Test Questions: Linux Foundation Certified IT Associat 🥅 Search on ⏩ www.pdfvce.com ⏪ for ⇛ LFCA ⇚ to obtain exam materials for free download 🌱LFCA Vce Exam” – Page 8

Validation and correlations of the angioedema activity score (AAS), angioedema quality of life (AE-QoL) questionnaire, and angioedema control test (AECT) in Chinese patients with angioedema

607.

Mak, H. W. F., Wong, J. C. Y., So, S. W. M., Lam, D. L. Y., Weller, K., Maurer, M., and Li, P. H.⁺: Validation and correlations of the angioedema activity score (AAS), angioedema quality of life (AE-QoL) questionnaire, and angioedema control test (AECT) in Chinese patients with angioedema. J. Allergy Clin. Immunol. Glob. 2024: 3; 100295. IF: N/A

o.607

Recommendations for assessing Patient-Reported Outcomes and Health-Related quality of life in clinical trials on allergy: a GA²LEN taskforce position paper

Baiardini, I.+, Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., Fokkens, W., van Wijk, G. R., La Grutta, S., Lombardi, C., Maurer, M. Pinto, A. M., Ridolo, E., Senna, G. E., Terreehorst, I., Bom, A. T., Bousquet, J., Zuberbier, T., and Braido, F.: Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: A GA²LEN taskforce position paper. Allergy 2010: 65; 290-295. IF: 6.29

o.090

81.	Maurer, M., Magerl, M., Metz, M., and Zuberbier, T.: Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria. J. Dtsch. Dermatol. Ges. 2013: 11; 971-978. IF: 1.81

417.	Liao, S. L., Yu, M., Zhao, Z.^, and Maurer, M.^+: Case Report: Omalizumab for chronic spontaneous urticaria in pregnancy. Front. Immunol. 2021: 12; 652973. IF: 8.79

o.417

291	Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: Comparison and interpretability of the available urticaria activity scores. Allergy 2018: 73; 251-255. IF: 6.77

Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcɛRI-positive cells in the skin

269

Metz, M., Staubach, P., Bauer, A., Brehler, R., Gericke, J., Kangas, M., Ashton-Chess, J., Jarvis, P., Georgiou, P., Canvin, J., Hillenbrand, R., Erpenbeck, V. J., and Maurer, M.+: Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcɛRI-positive cells in the skin. Theranostics 2017: 7; 1266-1276. IF: 8.54

144	Konstantinou, G. N., Asero, R., Ferrer, M., Knol, E. F., Maurer, M. Raap, U., Schmid-Grendelmeier, P., Skol, P. S., and Grattan, C. E. H.+: EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 2013: 68; 27-36. IF: 5.99

26	Gommerman, J. L., Oh, D. Y., Zhou, X., Tedder, T. F., Maurer, M. Galli, S. J., and Carroll, M. C.⁺: A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J. Immunol. 2000: 165; 6915-6921. IF: 6.83

o.026

154	Kolkhir, P., Altrichter, S., Muñoz, M., Hawro, T., and Maurer, M.+: New treatments for chronic urticaria. Ann. Allergy Asthma Immunol. 2020: 124; 2-12. IF: 6.35

r.154

351	*Maurer, M.+*, Raap, U., Staubach, P., Richter-Huhn, G., Bauer, A., Oppel, E. M., Hillen, U., Bäumer, D., Reinhardt, M., and Chapman-Rothe, N.: Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study. Clin. Exp. Allergy 2019: 49; 655-662. IF: 4.22

o.351

Results